U.S. Code, Title 21, Food and Drugs

Contents:
Author: "U.S. Congress, Office of the Law Revision Counsel"

Show Summary

§ 1701. Definitions

     In this chapter:

(1) Demand reduction

     The term "demand reduction" means any activity conducted by a National Drug Control Program agency, other than an enforcement activity, that is intended to reduce the use of drugs, including—

     (A) drug abuse education;

     (B) drug abuse prevention;

     (C) drug abuse treatment;

     (D) drug abuse research;

     (E) drug abuse rehabilitation;

     (F) drug-free workplace programs; and

     (G) drug testing.

(2) Director

     The term "Director" means the Director of National Drug Control Policy.

(3) Drug

     The term "drug" has the meaning given the term "controlled substance" in section 802(6) of this title.

(4) Drug control

     The term "drug control" means any activity conducted by a National Drug Control Program agency involving supply reduction or demand reduction.

(5) Fund

     The term "Fund" means the fund established under section 1702(d) of this title.

(6) National Drug Control Program

     The term "National Drug Control Program" means programs, policies, and activities undertaken by National Drug Control Program agencies pursuant to the responsibilities of such agencies under the National Drug Control Strategy.

(7) National Drug Control Program agency

     The term "National Drug Control Program agency" means any agency that is responsible for implementing any aspect of the National Drug Control Strategy, including any agency that receives Federal funds to implement any aspect of the National Drug Control Strategy, but does not include any agency that receives funds for drug control activity solely under the National Foreign Intelligence Program, the Joint Military Intelligence Program or Tactical Intelligence and Related Activities, unless such agency has been designated—

     (A) by the President; or

     (B) jointly by the Director and the head of the agency.

(8) National Drug Control Strategy

     The term "National Drug Control Strategy" means the strategy developed and submitted to Congress under section 1705 of this title.

(9) Office

     Unless the context clearly implicates otherwise, the term "Office" means the Office of National Drug Control Policy established under section 1702(a) of this title.

(10) State and local affairs

     The term "State and local affairs" means domestic activities conducted by a National Drug Control Program agency that are intended to reduce the availability and use of drugs, including—

     (A) coordination and facilitation of Federal, State, and local law enforcement drug control efforts;

     (B) promotion of coordination and cooperation among the drug supply reduction and demand reduction agencies of the various States, territories, and units of local government; and

     (C) such other cooperative governmental activities which promote a comprehensive approach to drug control at the national, State, territory, and local levels.

(11) Supply reduction

     The term "supply reduction" means any activity of a program conducted by a National Drug Control Program agency that is intended to reduce the availability or use of drugs in the United States and abroad, including—

     (A) international drug control;

     (B) foreign and domestic drug intelligence;

     (C) interdiction; and

     (D) domestic drug law enforcement, including law enforcement directed at drug users.

(Pub. L. 105–277, div. C, title VII, § 702, Oct. 21, 1998, 112 Stat. 2681–670.)

Repeal of Section

For repeal of section on Sept. 30, 2003, see section 1712 of this title.

References in Text

     This chapter, referred to in text, was in the original "this title", meaning title VII of div. C of Pub. L. 105–277, Oct. 21, 1998, 112 Stat. 2681–670, known as Office of National Drug Control Policy Reauthorization Act of 1998, which is classified principally to this chapter. For complete classification of title VII to the Code, see Short Title note set out below and Tables.

Short Title

     Pub. L. 105–277, div. C, title VII, § 701, Oct. 21, 1998, 112 Stat. 2681–670, provided that: "This title [enacting this chapter, amending section 1509 of this title, sections 5312 to 5314 of Title 5, Government Organization and Employees, section 1105 of Title 31, Money and Finance, and section 402 of Title 50, War and National Defense] may be cited as the `Office of National Drug Control Policy Reauthorization Act of 1998’."

Ex. Ord. No. 13165. White House Task Force on Drug Use in Sports and United States Representative on the Board of the World Anti-Doping Agency

     Ex. Ord. No. 13165, Aug. 9, 2000, 65 F.R. 49469, provided:

     By the authority vested in me as President by the Constitution and the laws of the United States of America, including the Office of National Drug Control [Policy] Reauthorization Act of 1998, (21 U.S.C. 1701et seq.), and in order to develop recommendations for Federal agency actions to address the use of drugs in sports, in particular among young people, it is hereby ordered as follows:

     Section 1. Policy. The use of drugs in sports has reached a level that endangers not just the legitimacy of athletic competition but also the lives and health of athletes—from the elite ranks to youth leagues. The National Household Survey on Drug Abuse issued in 1999 found that in just 1 year’s time the rate of steroid use among young people rose roughly 50 percent among both sexes and across all age groups. It is the policy of my Administration to take the steps needed to help eliminate illicit or otherwise banned drug use and doping in sports at the State, national, and international level.

     Sec. 2. Establishment of a White House Task Force on Drug Use in Sports. (a) There is established a White House Task Force on Drug Use in Sports (Task Force). The Task Force shall comprise the co-vice chairs of the White House Olympic Task Force (the "Olympic Task Force Vice Chairs"), and representatives designated by the Office of National Drug Control Policy, the Department of Health and Human Services, the Department of Labor, the President’s Council on Physical Fitness and Sports, the Office of Management and Budget, the National Security Council, the Department of State, the Department of the Treasury, the Department of Education, the Department of Justice, the Department of Transportation, the National Institute on Drug Abuse, and the Substance Abuse and Mental Health Services Administration.

     (b) The Task Force shall develop recommendations for the President on further executive and legislative actions that can be undertaken to address the problem of doping and drug use in sports. In developing the recommendations, the Task Force shall consider, among other things: (i) the health and safety of America’s athletes, in particular our Nation’s young people; (ii) the integrity of honest athletic competition; and (iii) the views and recommendations of State and local governments, the private sector, citizens, community groups, and nonprofit organizations, on actions to address this threat. The Task Force, through its Chairs, shall submit its recommendations to the President.

     (c) The Director of the Office of National Drug Control Policy (the Director), the Secretary of the Department of Health and Human Services, and the Olympic Task Force Vice Chairs or their designees shall serve as the Task Force Chairs.

     (d) To the extent permitted by law and at the request of the Chairs, agencies shall cooperate with and provide information to the Task Force.

     Sec. 3. Participation in the World Anti-Doping Agency. (a) As part of my Administration’s efforts to address the problem of drug use in sports, the United States has played a leading role in the formation of a World Anti-Doping Agency (WADA) by the Olympic and sports community and the nations of the world. Through these efforts, the United States has been selected to serve as a governmental representative on the board of the WADA. This order will authorize the Director to serve as the United States Government’s representative on the WADA board.

     (b) Pursuant to 21 U.S.C. 1701et seq., the Director, or in his absence his designee, is hereby authorized to take all necessary and proper actions to execute his responsibilities as United States representative to the WADA.

     (c) To assist the Director in carrying out these responsibilities as the United States Government representative to the WADA and to the extent permitted by law, Federal employees may serve in their official capacity, inter alia, on WADA Committees or WADA advisory committees, serving as experts to the WADA.

William J. Clinton.

Section Referred to in Other Sections

     This section is referred to in section 1702 of this title.

Contents:

Related Resources

None available for this document.

Download Options


Title: U.S. Code, Title 21, Food and Drugs

Select an option:

*Note: A download may not start for up to 60 seconds.

Email Options


Title: U.S. Code, Title 21, Food and Drugs

Select an option:

Email addres:

*Note: It may take up to 60 seconds for for the email to be generated.

Chicago: "U.S. Congress, Office of the Law Revision Counsel", "§ 1701. Definitions," U.S. Code, Title 21, Food and Drugs in U.S. Code, Title 21, Food and Drugs (Washington, D.C.: Government Printing Office, 2002), Original Sources, accessed January 22, 2019, http://www.originalsources.com/Document.aspx?DocID=QCK6KZTC8QR9FQM.

MLA: "U.S. Congress, Office of the Law Revision Counsel". "§ 1701. Definitions." U.S. Code, Title 21, Food and Drugs, in U.S. Code, Title 21, Food and Drugs, Washington, D.C., Government Printing Office, 2002, Original Sources. 22 Jan. 2019. www.originalsources.com/Document.aspx?DocID=QCK6KZTC8QR9FQM.

Harvard: "U.S. Congress, Office of the Law Revision Counsel", '§ 1701. Definitions' in U.S. Code, Title 21, Food and Drugs. cited in 2002, U.S. Code, Title 21, Food and Drugs, Government Printing Office, Washington, D.C.. Original Sources, retrieved 22 January 2019, from http://www.originalsources.com/Document.aspx?DocID=QCK6KZTC8QR9FQM.